MarketPeel
Insider Trading Intelligence
JT

Joseph Todisco

CRMD
CHIEF EXECUTIVE OFFICER · CORMEDIX INC. · CIK 0001774807
FILING MIX · LIFETIME53%/47%
BUYS
40
SELLS
36
TOTAL VALUE
$4.21M
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
1,132,643
AVG SELL PX
$8.22
TRADE KIND
SHOWING 76 / 76
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Joseph Todisco, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+45.45%-1.51%-0.01%-1.50%-3.75%
14d11+63.64%-2.66%-0.69%-1.97%-3.04%
30d11+54.55%-5.11%-1.36%-3.75%-9.10%
60d11+54.55%-2.63%+0.34%-2.97%-3.01%
90d11+72.73%+0.19%+2.97%-2.78%+0.33%
180d11+81.82%-4.07%+6.17%-10.24%-7.88%
1y11(2 pending)+88.89%+23.57%+12.96%+10.61%-4.79%
2y11(2 pending)+88.89%+80.76%+34.80%+45.96%+8.82%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRMD · 774,749 shares · as of Feb 4, 2026
0193,687387,375581,062774,7492023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 40 buys / 36 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TLPH
TALPHERA, INC.
PURCHASEGRANT
Stock grant
30,70030,700Jun 22, 2026Jun 24, 2026View →
TLPH
TALPHERA, INC.
PURCHASEGRANT
Stock grant
5,10011,497Jun 22, 2026Jun 24, 2026View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
77,156774,749Feb 4, 2026Feb 6, 2026View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
225,900724,899Jan 23, 2026Jan 27, 2026View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
27,306$7.27$198.5K697,593Jan 23, 2026Jan 27, 2026View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
22,665$6.78$153.7K498,999Jan 17, 2026Jan 20, 2026View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
29,585$3.38$100.0K521,664Jan 16, 2026Jan 20, 2026View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
29,585411,245Jan 16, 2026Jan 20, 2026View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
17,417$7.15$124.5K492,079Jan 12, 2026Jan 20, 2026View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
30,000370,000Dec 18, 2025Dec 19, 2025View →
CRMD
CORMEDIX INC.
SALE10b5-1
10b5-1 plan
30,000$12.00$360.0K509,496Dec 18, 2025Dec 19, 2025View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
30,000$4.43$132.9K539,496Dec 18, 2025Dec 19, 2025View →
TLPH
TALPHERA, INC.
PURCHASEGRANT
Stock grant
6,3976,397Oct 15, 2025Oct 16, 2025View →
TLPH
TALPHERA, INC.
PURCHASEGRANT
Stock grant
38,38138,381Oct 15, 2025Oct 16, 2025View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
50,000216,667Sep 12, 2025Sep 12, 2025View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
50,000$13.00$650.0K509,496Sep 12, 2025Sep 12, 2025View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
50,000$3.47$173.5K559,496Sep 12, 2025Sep 12, 2025View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
21,225$11.66$247.5K509,496May 10, 2025Sep 12, 2025View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
59,170440,830Apr 1, 2025Apr 2, 2025View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
59,170$3.38$200.0K530,721Apr 1, 2025Apr 2, 2025View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
23,977$12.17$291.8K471,551Jan 17, 2025Jan 22, 2025View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
187,500495,528Jan 17, 2025Jan 22, 2025View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
17,829$11.19$199.5K308,028Jan 10, 2025Jan 14, 2025View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
26,982$5.17$139.5K325,857May 10, 2024May 13, 2024View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
13,561$3.74$50.7K352,839Mar 13, 2024Mar 13, 2024View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
133,333353,059Jan 12, 2024Jan 17, 2024View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
266,667266,667Jan 12, 2024Jan 17, 2024View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
13,781$3.47$47.8K339,278Jan 12, 2024Jan 17, 2024View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
10,000$3.71$37.1K219,726Sep 8, 2023Sep 8, 2023View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
5,000$4.58$22.9K209,726May 17, 2023May 17, 2023View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
5,000$4.58$22.9K209,726May 17, 2023May 18, 2023View →
CRMD
CORMEDIX INC.
SALE
Chief Executive Officer
37,443$5.30$198.4K204,726May 10, 2023May 12, 2023View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
400,000400,000Jan 14, 2023Jan 18, 2023View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
20,000$3.82$76.4K242,169Nov 15, 2022Nov 16, 2022View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
4,700$3.92$18.4K222,169Aug 24, 2022Aug 25, 2022View →
CRMD
CORMEDIX INC.
PURCHASE
Chief Executive Officer
10,000$3.38$33.8K217,469May 16, 2022May 17, 2022View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
500,000500,000May 10, 2022May 12, 2022View →
CRMD
CORMEDIX INC.
PURCHASEGRANT
Stock grant
207,469207,469May 10, 2022May 12, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President
4,442328,756May 7, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
4,4420May 7, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
1,562$3.40$5.3K327,194May 7, 2022May 10, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
289,856289,856Mar 3, 2022Mar 3, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
144,928144,928Mar 3, 2022Mar 3, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
26,54479,634Mar 1, 2022Mar 3, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
11,11111,111Mar 1, 2022Mar 3, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
3,906$4.45$17.4K307,101Mar 1, 2022Mar 3, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President
11,111311,007Mar 1, 2022Mar 3, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
9,331$4.45$41.5K324,314Mar 1, 2022Mar 3, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President
26,544333,645Mar 1, 2022Mar 3, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
29,68459,367Feb 27, 2022Mar 1, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
11,107$4.59$51.0K299,896Feb 27, 2022Mar 1, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President
29,684311,003Feb 27, 2022Mar 1, 2022View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
1,500$4.10$6.2K281,319Dec 2, 2021Dec 3, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President
4,441284,381May 7, 2021May 11, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
4,4414,442May 7, 2021May 11, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
1,562$5.20$8.1K282,819May 7, 2021May 11, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
36,33036,331Mar 15, 2021Mar 17, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President
36,330$2.75$99.9K316,270Mar 15, 2021Mar 17, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
36,330$6.82$247.9K279,940Mar 15, 2021Mar 17, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President
11,111283,846Mar 1, 2021Mar 2, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
3,906$5.18$20.2K279,940Mar 1, 2021Mar 2, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
11,11122,222Mar 1, 2021Mar 2, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
212,356212,356Mar 1, 2021Mar 3, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
106,178106,178Mar 1, 2021Mar 3, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
10,972$5.39$59.1K272,735Feb 27, 2021Mar 2, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President
29,68389,051Feb 27, 2021Mar 2, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President
29,683283,707Feb 27, 2021Mar 2, 2021View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
SVP, Specialty Commercial
4,442256,236May 7, 2020May 8, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
SVP, Specialty Commercial
2,212$3.55$7.9K254,024May 7, 2020May 8, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
SVP, Specialty Commercial
4,4428,883May 7, 2020May 8, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
SVP, Specialty Commercial
11,11133,333Mar 1, 2020Mar 3, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
SVP, Specialty Commercial
6,162$3.85$23.7K251,794Mar 1, 2020Mar 3, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
SVP, Specialty Commercial
11,111257,956Mar 1, 2020Mar 3, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
SVP, Specialty Commercial
40,000$3.62$144.8K246,845Feb 28, 2020Mar 3, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
237,468237,468Feb 27, 2020Mar 2, 2020View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
118,734118,734Feb 27, 2020Mar 2, 2020View →
Other insiders · CRMD
Loading peer insiders…
About this filer
CIK 0001774807
ROLE
Chief Executive Officer
PRIMARY
CRMD
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001774807DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback